Evidentic is the first provider to offer therapeutic antibodies from original EU-licensed drugs as research consumables. Evidentic thus solves a central problem of the biosimilar manufacturers: to source different batches of biotechnologically manufactured drugs usually not available on the market at the same time. For researchers in industry and universities our business model allows to buy therapeutic antibodies as consumables.